Fundraising Fox
Cullgen
Founded 2018 · 25 employees on LinkedIn · 2 known investors
Find your way into Cullgen
Sign up to see every warm intro you have to Cullgen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cullgen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.
Founders & leadership
Cullgen was founded in 2018 by Ying Luo.
Investors · 2
How we know: 3E Bioventures Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Cullgen do?
- Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.
- Who founded Cullgen?
- Cullgen was founded by Ying Luo in 2018.
- Who are Cullgen's investors?
- Cullgen's investors include 3E Bioventures Capital, HongShan Capital Group.